05.08.2011 • News

Huntsman Q2 Adjusted Profit Up

Huntsman posted second-quarter net income attributable to the company of $114 million or $0.47 per share, flat with last year. Adjusted net income for the second quarter rose to $117 million or $0.48 per share from $75 million or $0.31 per share in the year-ago quarter.

Analysts polled by Thomson Reuters expected the company to earn $0.49 per share in the quarter. Analysts' estimates typically exclude special items.

Revenues were $2.93 billion versus $2.34 billion last year. The Street estimated revenues of $2.77 billion for the quarter.

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.